About iBET
iBET is a Healthcare company based in Oeiras (Portugal) founded in 1989 by Manuel Carrondo. Genomics and analytical services are provided by iBET in Portugal. iBET offers products and services including Vaccine Development, Gene Therapy Products, and Bioprocess Engineering. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Analytical Testing.
Company details
iBET was established in 1989 in Oeiras, Portugal, within the biotechnology sector. Genomics and analytical services are delivered by the company, supporting research and development in life sciences. Operations are centered in Portugal, with a focus on advanced analytical techniques and genomic applications for various industries. The founder and vice president role is held by Manuel Carrondo, guiding strategic initiatives in this field.
- Latest Funding Round$13.64K (USD), Grant
Feb 2022
- Investors
Products & Services of iBET
iBET offers a comprehensive portfolio of products and services, including Vaccine Development, Gene Therapy Products, and Bioprocess Engineering.
Research and production of vaccines for disease prevention
Advanced technologies for gene-based therapeutic solutions
Design of processes for cell-based therapies and drug discovery
Apps and channels of iBET
its YouTube channel iBET Portugal has 83 subscribers and 16 videos.
Videos from iBET
The most watched videos on iBET's YouTube channel, iBET Portugal (83 subscribers). Click a video to play it here.
More on iBET Portugal.
Funding Insights of iBET
- Total Rounds 20
- Last Round Grant — $13,636
- Investors Count 1
Latest 10 of 20 funding rounds of iBET with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2022 | $13,636 | Grant | – | – | |
| Oct 2020 | $961,442 | Grant | – | – | |
| Jun 2020 | $733,799 | Grant | – | – | |
| Jan 2020 | $462,499 | Grant | – | – | |
| Jun 2019 | $394,587 | Grant | – | – | |
| Apr 2019 | $332,043 | Grant | – | – | |
| Jan 2019 | $337,633 | Grant | – | – | |
| Jan 2019 | $639,788 | Grant | – | – | |
| Jun 2018 | $391,233 | Grant | – | – | |
| Feb 2018 | $850,169 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in iBET
iBET has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for iBET
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of iBET
32 people are tracked at iBET (22 in leadership, 10 in team).
| Name | Role | Group |
|---|---|---|
Manuel Carrondo | Founder & VP | Leadership |
Patrícia Gomes - Alves | Head Of Lab | Leadership |
Antonio Roldao | Head Of Vaccines Development Lab | Leadership |
Catarina Brito | Head Of Lab | Leadership |
Margarida Serra | Head Of Lab | Leadership |
Teresa Serra | Head Of Area | Leadership |
António Roldão | Head Of Lab | Leadership |
João Clemente | Head Of Unit | Leadership |
Lara Silva | Head Of Operations | Leadership |
Ana Figueiredo | Head Of People & Culture | Leadership |
Pedro Cruz | Chief Technical Operations Officer | Leadership |
Tiago Bandeiras | Head Of Lab | Leadership |
Ana Coroadinha | Head Of Lab | Leadership |
António Cunha | Head Of Unit | Leadership |
Luís Morais | Head Of Finance Department | Leadership |
Ana Paula Batista | Head Of Lab | Leadership |
Paula Alves | CEO | Leadership |
Daniel Simão | Head Of Lab | Leadership |
Teresa Crespo | Head Of Area | Leadership |
Tânia Costa | Head Of People & Culture | Leadership |
12 more people are available in the full profile.
Complete people profiles for iBET
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of iBET
3 dated milestones of iBET across 33 years, from founding to its latest funding, stage changes and deals.
- Founded iBET is founded.
- Funding First funding round.
- Funding Latest funding round, Grant, of $14K.
Web traffic of iBET
The website of iBET (ibet.pt) receives about 6.6K visits a month.
- Monthly visits6.6K
▼ 31.8% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Ibet
Complete news archive for iBET
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about iBET
iBET was founded in 1989 and raised its 1st funding round 25 years after it was founded.
iBET is headquartered in Oeiras, Portugal.
iBET was established in 1989 in Oeiras, Portugal, within the biotechnology sector. Genomics and analytical services are delivered by the company, supporting research and development in life sciences. Operations are centered in Portugal, with a focus on advanced analytical techniques and genomic applications for various industries. The founder and vice president role is held by Manuel Carrondo, guiding strategic initiatives in this field.
iBET offers Vaccine Development, Gene Therapy Products, and Bioprocess Engineering.
iBET has 1 investor. Key investors include European Union.